Physician profile
Erin S Cooper
NPI 1013297910
$2,716.42
in general payments reported to CMS, 2019-2025
16 companies · $835 in 2025
The $835 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2021: $64.53 · 2022: $748 · 2023: $432 · 2024: $378 · 2025: $835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,644.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $730.83 | 2021-2024 | Misight Contact Lens, Biofinity Contact Lens |
| Bausch & Lomb Americas INC. | $464.73 | 2022-2025 | Infuse |
| Alcon Vision LLC | $408.09 | 2019-2025 | Acrysof Iq Vivity, Total30, Precision 7 |
| Johnson & Johnson Vision Care, INC. | $332.66 | 2022-2025 | Acuvue |
| Amgen INC. | $146.55 | 2024 | Tepezza |
| Dompe US, INC. | $136.65 | 2025 | Oxervate |
| Horizon Therapeutics Plc | $124.95 | 2023 | Tepezza |
| Lkc Technologies, INC. | $90.71 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $63.29 | 2019 | |
| Shire North American Group INC | $54.33 | 2019 | |
| Optovue, INC. | $48.39 | 2019 | |
| Abb Con-Cise Optical Group LLC | $41.64 | 2022 | |
| Eyevance Pharmaceuticals LLC | $19.95 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.89 | 2021 | |
| Aerie Pharmaceuticals, INC. | $18.33 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $16.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.